This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Definition Remove Due Diligence Remove FDA Remove Medicaid
article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

JANUARY 8, 2024

While each company successfully gained FDA approvals, the current market acceptance for prescription digital therapeutics is low and improvements will take years. They will continue to run clinical trials to confirm their claims and value proposition but will not seek FDA approvals.

Pharmaceutical Industry 114
Pharmaceutical Industry Due Diligence Compliance Regulatory Compliance 114
article thumbnail

Updated Compliance Tool for Developers of Mobile Health Apps

Hall Render

JANUARY 11, 2023

The Tool is a result of collaborative efforts between the FTC, HHS Office for Civil Rights (“OCR”), HHS Office of the National Coordinator for Health Information Technology (“ONC”) and the Food and Drug Administration (“FDA”). Regulatory Landscape.

Compliance 40
Compliance HIPAA FDA Due Diligence 40
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 50,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024